Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
Inspection Record
Laboratorios Grifols, S.A. — FDA 483 Findings
Inspectors Irina GabermanThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Laboratory records are deficient in that they do not include a complete record of all data obtained during testing.
Written procedures for cleaning and maintenance fail to include description in sufficient detail of methods, equipment and materials used.
The batch production and control records are deficient in that they do not include documentation of the accomplishment of each significant step in manufacturing.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Shimoga Chemicals2026-01-23 · US FDASimilar to finding 1 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
- VitaCare Labs Inc.2025-05-16 · US FDASimilar to finding 1 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
- Imprimis NJOF LLC2026-08-18 · US FDASimilar to finding 1 Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength…
- Sun Pharmaceuticals Industries Limited2022-08-12 · US FDASimilar to finding 2 Laboratory records are deficient in that they do not include a complete record of all data obtained during testing.
- OPS International Inc dba Olympia Pharmaceuticals2026-09-03 · US FDASimilar to finding 1 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
A record as of the US FDA document published on 2026-10-21. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.